Brookfield, Caisse de Depot Buy Antylia Scientific From GTCR for $1.34B

Dow Jones

May 28

By Robb M. Stewart

Brookfield Asset Management and Caisse de depot et placement du Quebec have bought life-sciences company Antylia Scientific from private-equity firm GTCR for roughly $1.34 billion.

The purchase of the Illinois-based business marks Brookfield's latest transaction in the U.S. industrial and manufacturing sector, following a deal earlier this year for electric heat-trace systems company Chemelex.

Antylia manufacturers and sells products that support the accuracy and repeatability of processes in labs.

GTCR bought Antylia from Thermo Fisher Scientific in a carve-out transaction in 2014, and has invested in the company to help expand its geographic reach and portfolio of products over the years. Antylia has since 2014 completed 15 acquisitions of complementary life-science tools and diagnostic-controls businesses, and in late 2021 it separated and divested its Masterflex bioprocessing business segment to Avantor in an all-cash transaction that valued the unit at $2.9 billion.

Write to Robb M. Stewart at robb.stewart@wsj.com

(END) Dow Jones Newswires

May 28, 2025 09:47 ET (13:47 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2538229471"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2538229471\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2538229471?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-28 21:47","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2538229471","market":"sh","top_or_hot":-1,"title":"Brookfield, Caisse de Depot Buy Antylia Scientific From GTCR for $1.34B","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Robb M. Stewart \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/BN\">Brookfield</a> Asset Management and Caisse de depot et placement du Quebec have bought life-sciences company Antylia Scientific from private-equity firm GTCR for roughly $1.34 billion. \n</p>\n<p>\n  The purchase of the Illinois-based business marks Brookfield's latest transaction in the U.S. industrial and manufacturing sector, following a deal earlier this year for electric heat-trace systems company Chemelex. \n</p>\n<p>\n  Antylia manufacturers and sells products that support the accuracy and repeatability of processes in labs. \n</p>\n<p>\n  GTCR bought Antylia from Thermo Fisher Scientific in a carve-out transaction in 2014, and has invested in the company to help expand its geographic reach and portfolio of products over the years. Antylia has since 2014 completed 15 acquisitions of complementary life-science tools and diagnostic-controls businesses, and in late 2021 it separated and divested its Masterflex bioprocessing business segment to Avantor in an all-cash transaction that valued the unit at $2.9 billion. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Robb M. Stewart at robb.stewart@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 28, 2025 09:47 ET (13:47 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Brookfield, Caisse de Depot Buy Antylia Scientific From GTCR for $1.34B</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBrookfield, Caisse de Depot Buy Antylia Scientific From GTCR for $1.34B\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-05-28 21:47</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Robb M. Stewart \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/BN\">Brookfield</a> Asset Management and Caisse de depot et placement du Quebec have bought life-sciences company Antylia Scientific from private-equity firm GTCR for roughly $1.34 billion. \n</p>\n<p>\n  The purchase of the Illinois-based business marks Brookfield's latest transaction in the U.S. industrial and manufacturing sector, following a deal earlier this year for electric heat-trace systems company Chemelex. \n</p>\n<p>\n  Antylia manufacturers and sells products that support the accuracy and repeatability of processes in labs. \n</p>\n<p>\n  GTCR bought Antylia from Thermo Fisher Scientific in a carve-out transaction in 2014, and has invested in the company to help expand its geographic reach and portfolio of products over the years. Antylia has since 2014 completed 15 acquisitions of complementary life-science tools and diagnostic-controls businesses, and in late 2021 it separated and divested its Masterflex bioprocessing business segment to Avantor in an all-cash transaction that valued the unit at $2.9 billion. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Robb M. Stewart at robb.stewart@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 28, 2025 09:47 ET (13:47 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1057294990.SGD","symbol_name":"Blackrock World Healthscience A2 SGD-H","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2538229471","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2538229471","pubTimestamp":1748440020,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Brookfield Asset Management and Caisse de depot et placement du Quebec have bought life-sciences company Antylia Scientific from private-equity firm GTCR for roughly $1.34 billion.The purchase of the Illinois-based business marks Brookfield's latest transaction in the U.S. industrial and manufacturing sector, following a deal earlier this year for electric heat-trace systems company Chemelex.Antylia manufacturers and sells products that support the accuracy and repeatability of processes in labs.GTCR bought Antylia from Thermo Fisher Scientific in a carve-out transaction in 2014, and has invested in the company to help expand its geographic reach and portfolio of products over the years. Antylia has since 2014 completed 15 acquisitions of complementary life-science tools and diagnostic-controls businesses, and in late 2021 it separated and divested its Masterflex bioprocessing business segment to Avantor in an all-cash transaction that valued the unit at $2.9 billion.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","LU0061474960.USD":"天利环球焦点基金AU Acc","LU0557290698.USD":"施罗德环球可持续增长基金","LU2298321311.HKD":"BGF CIRCULAR ECONOMY \"A\" (HKDHDG) ACC","LU0528227936.USD":"富达环球人口趋势基金A-ACC","LU2125909247.SGD":"Natixis Thematics Meta H-R/A SGD","LU1720051017.SGD":"Allianz Global Artificial Intelligence AT Acc H2-SGD","LU2089984988.USD":"MANULIFE GF HEALTHCARE \"AA\" (USD) ACC","LU0316494557.USD":"FRANKLIN GLOBAL FUNDAMENTAL STRATEGIES \"A\" ACC","LU1854104046.USD":"M&G (LUX) POSITIVE IMPACT \"A\" (USD) ACC","LU2357305700.SGD":"Allianz Global Artificial Intelligence ET H2-SGD","LU1923622614.USD":"Natixis Thematics Meta R/A USD","LU1548497426.USD":"安联环球人工智能AT Acc","BK4581":"高盛持仓","LU1791710582.SGD":"Fidelity Global Demographics A-ACC-SGD (SGD/USD hedged)","TMO":"赛默飞世尔","LU2112291526.USD":"BGF WORLD HEALTHSCIENCE \"A4\" (USD) INC","BK4121":"生命科学工具和服务","LU0342679015.USD":"ALLIANZ GLOBAL EQUITY UNCONSTRAINED \"AT\" (USD) ACC","IE00B19Z8W00.USD":"FTGF CLEARBRIDGE US LARGE CAP GROWTH \"A\" INC","IE00BJJMRZ35.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (SGDHDG) ACC","LU0011850046.USD":"贝莱德全球长线股票 A2 USD","IE00BFTCPJ56.SGD":"Janus Henderson Global Life Sciences A Acc SGD","LU0957791311.USD":"THREADNEEDLE (LUX) GLOBAL FOCUS \"ZU\" (USD) ACC","BK4585":"ETF&股票定投概念","BK4534":"瑞士信贷持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","IE00B4R5TH58.HKD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (HKD) ACC","LU0882574055.USD":"富达全球健康医疗A ACC","AVTR":"Avantor, Inc.","LU1280957306.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQUITIES \"AUP\" (USD) INC","IE00B1BXHZ80.USD":"Legg Mason ClearBridge - US Appreciation A Acc USD","LU0823416689.USD":"BNP PARIBAS HEALTH CARE INNOVATORS \"C\" (USD) ACC","LU0234572021.USD":"高盛美国核心股票组合Acc","LU2433249047.HKD":"THEMATICS META \"R/A\" (HKD) ACC","BK4535":"淡马锡持仓","LU2125910179.SGD":"Natixis Thematics Water H-R/A SGD","LU1291159041.SGD":"CPR Invest - Global Silver Age A2 Acc SGD-H","LU1923621640.USD":"Natixis Thematics Water R/A USD","IE0034235188.USD":"PINEBRIDGE GLOBAL FOCUS EQUITY \"A\" (USD) ACC","LU2764263039.SGD":"BGF GLOBAL UNCONSTRAINED EQUITY \"A2\" (SGDHDG) ACC","LU1988902786.USD":"FULLERTON LUX FUNDS GLOBAL ABSOLUTE ALPHA \"I\" (USD) ACC","IE00B19Z9505.USD":"美盛-美国大盘成长股A Acc","LU0266013472.USD":"AXA WF - Framlington Longevity Economy A Cap USD","LU2764263203.CNY":"BGF GLOBAL UNCONSTRAINED EQUITY \"A2\" (CNYHDG) ACC","IE0009355771.USD":"骏利亨德森环球生命科技A Acc","BK4588":"碎股","LU2125910336.SGD":"Natixis Thematics Water R/A SGD","BK4548":"巴美列捷福持仓","LU2360108059.USD":"BGF CIRCULAR ECONOMY \"A4\" (USD) INC"},"translate_title":"Brookfield、Caisse de Depot以$1.34 B从GTCR手中收购Antylia Scientific","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TMO":0.9,"AVTR":0.9},"content_text":"By Robb M. Stewart \n\n\n \n\n\nBrookfield Asset Management and Caisse de depot et placement du Quebec have bought life-sciences company Antylia Scientific from private-equity firm GTCR for roughly $1.34 billion. \n\n\n  The purchase of the Illinois-based business marks Brookfield's latest transaction in the U.S. industrial and manufacturing sector, following a deal earlier this year for electric heat-trace systems company Chemelex. \n\n\n  Antylia manufacturers and sells products that support the accuracy and repeatability of processes in labs. \n\n\n  GTCR bought Antylia from Thermo Fisher Scientific in a carve-out transaction in 2014, and has invested in the company to help expand its geographic reach and portfolio of products over the years. Antylia has since 2014 completed 15 acquisitions of complementary life-science tools and diagnostic-controls businesses, and in late 2021 it separated and divested its Masterflex bioprocessing business segment to Avantor in an all-cash transaction that valued the unit at $2.9 billion. \n\n\n \n\n\n  Write to Robb M. Stewart at robb.stewart@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 28, 2025 09:47 ET (13:47 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}